Copay Freeze for Veterans Extended Through 2016

By Allison Gilchrist

Veterans who obtain their prescriptions at a VA pharmacy will see their copays remain steady through 2016.

Under a new rule published in the Federal Register on September 16, 2015, the Department of Veterans Affairs (VA) will extend its freeze on co-payment increases until at least December 31, 2016.

This federal rule comes as a relief for VA officials who expressed concerns that veterans would reduce their use of pharmacy benefits if their co-pays increased, thus affecting their adherence to prescribed medication regimens.

Currently, veterans must pay a portion of their prescription drug costs for non-service-related conditions if their income exceeds established thresholds. Depending on their eligibility status in the VA system, this can translate to $8 or $9 per 30-day prescription.

While the co-pay freeze is a victory for veterans’ health, some other recent policy changes may negatively affect veterans and their families.

Read the rest of the article here.

By Allison Gilchrist

Veterans who obtain their prescriptions at a VA pharmacy will see their copays remain steady through 2016.

Under a new rule published in the Federal Register on September 16, 2015, the Department of Veterans Affairs (VA) will extend its freeze on co-payment increases until at least December 31, 2016.

This federal rule comes as a relief for VA officials who expressed concerns that veterans would reduce their use of pharmacy benefits if their co-pays increased, thus affecting their adherence to prescribed medication regimens.

Currently, veterans must pay a portion of their prescription drug costs for non-service-related conditions if their income exceeds established thresholds. Depending on their eligibility status in the VA system, this can translate to $8 or $9 per 30-day prescription.

While the co-pay freeze is a victory for veterans’ health, some other recent policy changes may negatively affect veterans and their families.

Read the rest of the article here.